You can buy or sell Medigus and other stocks, options, and ETFs commission-free!
Medigus Ltd. engages in research and development of medical treatment for the gastrointestinal tract. Its product is the MUSE system, an endoscopic device to perform Transoral Fundoplication for the treatment of gastroesophageal reflux disease. The company was founded by Elazar Sonnenschein on December 9, 1999 and is headquartered in Omer, Israel. The listed name for MDGS is Medigus Ltd. American Depositary Shares.
52 Week High
52 Week Low